Iris Appelmann

587 total citations
22 papers, 438 citations indexed

About

Iris Appelmann is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Genetics. According to data from OpenAlex, Iris Appelmann has authored 22 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 7 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Iris Appelmann's work include Acute Lymphoblastic Leukemia research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Iris Appelmann is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Iris Appelmann collaborates with scholars based in Germany, United States and Ireland. Iris Appelmann's co-authors include Wolfgang E. Berdel, Scott W. Lowe, Rüediger Liersch, Torsten Keßler, Rolf M. Mesters, Cornelius Miething, Julie Teruya‐Feldstein, Claudio Scuoppo, Seungtai Yoon and Lisa Lindqvist and has published in prestigious journals such as Nature, Blood and PLoS ONE.

In The Last Decade

Iris Appelmann

20 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris Appelmann Germany 11 236 108 78 70 59 22 438
Soumen Chakraborty India 13 434 1.8× 197 1.8× 60 0.8× 80 1.1× 39 0.7× 27 635
Syed K. Hasan India 12 295 1.3× 232 2.1× 65 0.8× 80 1.1× 78 1.3× 40 455
Mervat M. Khorshied Egypt 12 98 0.4× 73 0.7× 62 0.8× 44 0.6× 32 0.5× 46 342
Takahiko Yasuda Japan 12 269 1.1× 131 1.2× 33 0.4× 79 1.1× 69 1.2× 33 465
Carlos A Tirado United States 14 336 1.4× 247 2.3× 137 1.8× 112 1.6× 126 2.1× 80 660
Takuma Ishizaki Japan 11 193 0.8× 113 1.0× 54 0.7× 61 0.9× 13 0.2× 45 414
Bárbara Du Rocher Brazil 12 285 1.2× 62 0.6× 150 1.9× 133 1.9× 29 0.5× 19 496
Justin Aubin United States 6 160 0.7× 77 0.7× 101 1.3× 106 1.5× 33 0.6× 7 424
Christian Hurtz United States 10 246 1.0× 258 2.4× 107 1.4× 115 1.6× 162 2.7× 32 607
Catia Lo Pardo Italy 14 266 1.1× 242 2.2× 85 1.1× 78 1.1× 77 1.3× 18 507

Countries citing papers authored by Iris Appelmann

Since Specialization
Citations

This map shows the geographic impact of Iris Appelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Appelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Appelmann more than expected).

Fields of papers citing papers by Iris Appelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Appelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Appelmann. The network helps show where Iris Appelmann may publish in the future.

Co-authorship network of co-authors of Iris Appelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Appelmann. A scholar is included among the top collaborators of Iris Appelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Appelmann. Iris Appelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Appelmann, Iris, et al.. (2024). Feasibility of a physical exercise intervention for patients on a palliative care unit: a critical analysis. BMC Palliative Care. 23(1). 58–58. 2 indexed citations
2.
Mücke, Martin, et al.. (2024). Advance directives in amyotrophic lateral sclerosis – a systematic review and meta-analysis. BMC Palliative Care. 23(1). 191–191. 2 indexed citations
3.
Schemionek, Mirle, Michael Huber, Margherita Vieri, et al.. (2023). XBP1 promotes NRASG12D pre‐B acute lymphoblastic leukaemia through IL‐7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS. Journal of Cellular and Molecular Medicine. 27(21). 3363–3377. 1 indexed citations
4.
Salimi, Azam, Mirle Schemionek, Margherita Vieri, et al.. (2022). Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK. BMC Cancer. 22(1). 735–735. 19 indexed citations
5.
Appelmann, Iris, et al.. (2022). Der Einsatz von Cannabinoiden am Lebensende. MMW - Fortschritte der Medizin. 164(S5). 16–19.
6.
Appelmann, Iris, et al.. (2022). Spezialisierte ambulante Palliativversorgung (SAPV). Der Schmerz. 36(5). 371–380.
7.
Salimi, Azam, Margherita Vieri, Mirle Schemionek, et al.. (2022). Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia. PLoS ONE. 17(10). e0268352–e0268352. 1 indexed citations
8.
Appelmann, Iris, Azam Salimi, Michael Huber, et al.. (2020). Interplay between PI3K/mTOR Signaling and IRE1a-XBP1 Promotes Survival of Pre-B NRASG12D all Cells Providing a Therapeutic Vulnerability for the "Undruggable" Driver RAS. Blood. 136(Supplement 1). 47–48. 1 indexed citations
9.
Vieri, Margherita, Christian Preisinger, Mirle Schemionek, et al.. (2020). Targeting of BCR-ABL1 and IRE1α induces synthetic lethality in Philadelphia-positive acute lymphoblastic leukemia. Carcinogenesis. 42(2). 272–284. 10 indexed citations
10.
Herrmann, Oliver, Ivan G. Costa, Iris Appelmann, et al.. (2019). Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia. BMC Cancer. 19(1). 658–658. 14 indexed citations
11.
Lee, Jung‐Rok, Iris Appelmann, Cornelius Miething, et al.. (2018). Longitudinal Multiplexed Measurement of Quantitative Proteomic Signatures in Mouse Lymphoma Models Using Magneto-Nanosensors. Theranostics. 8(5). 1389–1398. 16 indexed citations
12.
Vieri, Margherita, Christian Preisinger, Mirle Schemionek, et al.. (2018). Synergistic Dual Inhibition of BCR-ABL1 and the Unfolded Protein Response Causes p38 MAPK-Mediated Cell Death and Sensitizes BCR-ABL1+ Acute Lymphoblastic Leukemia to Dexamethasone. Blood. 132(Supplement 1). 4674–4674. 2 indexed citations
13.
14.
Miething, Cornelius, Claudio Scuoppo, Benedikt Bosbach, et al.. (2014). PTEN action in leukaemia dictated by the tissue microenvironment. Nature. 510(7505). 402–406. 38 indexed citations
15.
Appelmann, Iris, Claudio Scuoppo, Vishal Thapar, et al.. (2014). Suppression of EZH2 Accelerates MYC-Driven Lymphomagenesis By Inhibition of Apoptosis. Blood. 124(21). 3009–3009. 1 indexed citations
16.
Scuoppo, Claudio, Cornelius Miething, Lisa Lindqvist, et al.. (2012). A tumour suppressor network relying on the polyamine–hypusine axis. Nature. 487(7406). 244–248. 104 indexed citations
17.
Liersch, Rüediger, Joachim Gerß, Christoph Schliemann, et al.. (2012). Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients. Blood. 119(22). 5215–5220. 52 indexed citations
18.
Pohlen, Michele, Hans Ulrich Gerth, Rüediger Liersch, et al.. (2011). Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B‐ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B‐cell lymphoma. American Journal of Hematology. 86(12). E61–4. 17 indexed citations
19.
Fendel, Rolf, Christian Brandts, Andrea Kreidenweiss, et al.. (2010). Hemolysis Is Associated with Low Reticulocyte Production Index and Predicts Blood Transfusion in Severe Malarial Anemia. PLoS ONE. 5(4). e10038–e10038. 37 indexed citations
20.
Appelmann, Iris, Rüediger Liersch, Torsten Keßler, Rolf M. Mesters, & Wolfgang E. Berdel. (2009). Angiogenesis Inhibition in Cancer Therapy. Recent results in cancer research. 180. 51–81. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soumen Chakraborty Breakdown of academic impact, for papers by Syed K. Hasan Breakdown of academic impact, for papers by Mervat M. Khorshied Breakdown of academic impact, for papers by Takahiko Yasuda Breakdown of academic impact, for papers by Carlos A Tirado Breakdown of academic impact, for papers by Takuma Ishizaki Breakdown of academic impact, for papers by Bárbara Du Rocher Breakdown of academic impact, for papers by Justin Aubin Breakdown of academic impact, for papers by Christian Hurtz Breakdown of academic impact, for papers by Catia Lo Pardo
Rankless by CCL
2026